Pacira BioSciences' Non-Current Assets fell 1165.0% to $734.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year decrease of 1997.91%. This contributed to the annual value of $808.4 million for FY2024, which is 2405.19% down from last year.
Latest data reveals that Pacira BioSciences reported Non-Current Assets of $734.8 million as of Q3 2025, which was down 1165.0% from $791.6 million recorded in Q2 2025.
Pacira BioSciences' Non-Current Assets' 5-year high stood at $1.2 billion during Q1 2022, with a 5-year trough of $533.3 million in Q2 2021.
For the 5-year period, Pacira BioSciences' Non-Current Assets averaged around $953.7 million, with its median value being $1.0 billion (2024).
Per our database at Business Quant, Pacira BioSciences' Non-Current Assets soared by 12649.21% in 2022 and then tumbled by 2405.19% in 2024.
Quarter analysis of 5 years shows Pacira BioSciences' Non-Current Assets stood at $1.2 billion in 2021, then fell by 2.19% to $1.2 billion in 2022, then fell by 10.02% to $1.1 billion in 2023, then decreased by 24.05% to $808.4 million in 2024, then dropped by 9.1% to $734.8 million in 2025.
Its Non-Current Assets stands at $734.8 million for Q3 2025, versus $791.6 million for Q2 2025 and $826.7 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value